Bioventus Inc.
BVS
DELAYED 1 MONTH
15 insider filings · Latest: Jun 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 13 9:26 PM | Michelle Mcmurry-HeathDirector | Sale | 12,000 | $8.79 | $105.4K | 44,997(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 17 9:03 PM | Mark Leonard SingletonSVP & CFO | Option Exercise | 13,500 | — | 40,500(D) | View → |
| Mar 13, 2026 | Mar 17 9:03 PM | Mark Leonard SingletonSVP & CFO | Grant/Award | 220,000 | $8.62 | 116,000(D) | View → |
| Mar 14, 2025 | Mar 17 9:03 PM | Mark Leonard SingletonSVP & CFO | Grant/Award | 115,000 | $9.61 | 61,000(D) | View → |
| Mar 13, 2026 | Mar 17 9:02 PM | Katrina J ChurchSVP & Chief Compliance Officer | Option Exercise | 6,955 | — | 10,500(D) | View → |
| Mar 13, 2026 | Mar 17 9:02 PM | Katrina J ChurchSVP & Chief Compliance Officer | Grant/Award | 51,000 | $8.62 | 27,000(D) | View → |
| Mar 14, 2025 | Mar 17 9:02 PM | Katrina J ChurchSVP & Chief Compliance Officer | Grant/Award | 30,000 | $9.61 | 16,000(D) | View → |
| Mar 13, 2026 | Mar 17 9:01 PM | Anthony D'AdamioSVP & General Counsel | Option Exercise | 17,636 | — | 26,250(D) | View → |
| Mar 13, 2026 | Mar 17 9:01 PM | Anthony D'AdamioSVP & General Counsel | Grant/Award | 175,000 | $8.62 | 92,000(D) | View → |
| Mar 14, 2025 | Mar 17 9:01 PM | Anthony D'AdamioSVP & General Counsel | Grant/Award | 75,000 | $9.61 | 40,000(D) | View → |
| Mar 13, 2026 | Mar 17 9:00 PM | Robert E ClaypooleDirector, President and CEO | Grant/Award | 587,000 | $8.62 | 309,000(D) | View → |
| Mar 13, 2026 | Mar 17 9:00 PM | Robert E ClaypooleDirector, President and CEO | Option Exercise | 33,500 | — | 100,500(D) | View → |
| Mar 14, 2025 | Mar 17 9:00 PM | Robert E ClaypooleDirector, President and CEO | Grant/Award | 287,000 | $9.61 | 153,000(D) | View → |
← Previous
Page 2 of 2